ECT2L
gene geneOn this page
Also known as ARHGEF32FBXO49LFDH
Summary
ECT2L (epithelial cell transforming 2 like, HGNC:21118) is a protein-coding gene on chromosome 6q24.1, encoding Epithelial cell-transforming sequence 2 oncogene-like (Q008S8). May act as a guanine nucleotide exchange factor (GEF).
Predicted to enable guanyl-nucleotide exchange factor activity.
Source: NCBI Gene 345930 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 165 total
- MANE Select transcript:
NM_001077706
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21118 |
| Approved symbol | ECT2L |
| Name | epithelial cell transforming 2 like |
| Location | 6q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ARHGEF32, FBXO49, LFDH |
| Ensembl gene | ENSG00000203734 |
| Ensembl biotype | protein_coding |
| Entrez | 345930 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000367682, ENST00000401414, ENST00000495970, ENST00000541398
RefSeq mRNA: 2 — MANE Select: NM_001077706
NM_001077706, NM_001195037
CCDS: CCDS43508
Canonical transcript exons
ENST00000541398 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001445363 | 138849269 | 138849434 |
| ENSE00001445364 | 138842979 | 138843231 |
| ENSE00001445368 | 138813172 | 138813340 |
| ENSE00001531504 | 138902500 | 138904070 |
| ENSE00001531506 | 138900948 | 138901120 |
| ENSE00001531511 | 138888943 | 138889031 |
| ENSE00001531513 | 138886857 | 138886922 |
| ENSE00001531516 | 138885674 | 138885830 |
| ENSE00001531519 | 138885506 | 138885579 |
| ENSE00001531522 | 138882724 | 138882871 |
| ENSE00001531525 | 138880957 | 138881171 |
| ENSE00001531528 | 138876472 | 138876558 |
| ENSE00001531550 | 138846539 | 138846677 |
| ENSE00001531553 | 138844412 | 138844580 |
| ENSE00001547299 | 138812838 | 138812977 |
| ENSE00001747099 | 138814491 | 138814603 |
| ENSE00003500465 | 138862627 | 138862719 |
| ENSE00003520793 | 138868103 | 138868206 |
| ENSE00003630928 | 138864996 | 138865178 |
| ENSE00003632506 | 138854026 | 138854154 |
| ENSE00003704874 | 138796087 | 138796192 |
| ENSE00003716460 | 138838352 | 138838514 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 88.88.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1382 / max 34.8197, expressed in 48 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 70124 | 0.0608 | 23 |
| 70123 | 0.0598 | 25 |
| 70125 | 0.0175 | 7 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 88.88 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.62 | gold quality |
| fallopian tube | UBERON:0003889 | 70.13 | gold quality |
| heart left ventricle | UBERON:0002084 | 62.61 | gold quality |
| right lung | UBERON:0002167 | 61.51 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.38 | gold quality |
| pituitary gland | UBERON:0000007 | 60.05 | gold quality |
| heart | UBERON:0000948 | 59.76 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 59.42 | silver quality |
| right atrium auricular region | UBERON:0006631 | 59.12 | gold quality |
| adenohypophysis | UBERON:0002196 | 57.22 | gold quality |
| endometrium | UBERON:0001295 | 56.72 | gold quality |
| ventricular zone | UBERON:0003053 | 56.49 | gold quality |
| lung | UBERON:0002048 | 56.25 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.93 | gold quality |
| cerebellar cortex | UBERON:0002129 | 54.89 | gold quality |
| cerebellum | UBERON:0002037 | 54.72 | gold quality |
| bone marrow cell | CL:0002092 | 54.68 | gold quality |
| Ammon’s horn | UBERON:0001954 | 54.44 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 53.89 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.72 | gold quality |
| corpus callosum | UBERON:0002336 | 53.71 | gold quality |
| mucosa of stomach | UBERON:0001199 | 53.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 53.43 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 52.72 | gold quality |
| hypothalamus | UBERON:0001898 | 52.59 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 52.18 | gold quality |
| granulocyte | CL:0000094 | 51.97 | gold quality |
| caudate nucleus | UBERON:0001873 | 51.82 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 51.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
62 targeting ECT2L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ect2l | ENSDARG00000091471 |
| mus_musculus | Ect2l | ENSMUSG00000071392 |
| rattus_norvegicus | Ect2l | ENSRNOG00000055142 |
| caenorhabditis_elegans | WBGENE00001366 | |
| caenorhabditis_elegans | WBGENE00001490 |
Paralogs (10): FARP2 (ENSG00000006607), FGD1 (ENSG00000102302), FGD3 (ENSG00000127084), ARHGEF39 (ENSG00000137135), FGD4 (ENSG00000139132), FGD2 (ENSG00000146192), FARP1 (ENSG00000152767), FGD5 (ENSG00000154783), FRMD7 (ENSG00000165694), FGD6 (ENSG00000180263)
Protein
Protein identifiers
Epithelial cell-transforming sequence 2 oncogene-like — Q008S8 (reviewed: Q008S8)
Alternative names: Lung-specific F-box and DH domain-containing protein, Putative guanine nucleotide exchange factor LFDH
All UniProt accessions (2): B7ZBI6, Q008S8
UniProt curated annotations — full annotation on UniProt →
Function. May act as a guanine nucleotide exchange factor (GEF).
RefSeq proteins (2): NP_001071174, NP_001181966 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000219 | DH_dom | Domain |
| IPR001810 | F-box_dom | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR025592 | DUF4347 | Domain |
| IPR035899 | DBL_dom_sf | Homologous_superfamily |
| IPR036047 | F-box-like_dom_sf | Homologous_superfamily |
| IPR052805 | GEF_Ubiquitin-Prot_Reg | Family |
Pfam: PF00621, PF12937, PF14252
UniProt features (10 total): sequence conflict 4, sequence variant 3, domain 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q008S8-F1 | 74.75 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 30 (showing top):
GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, PAX3_TARGET_GENES, ZNF22_TARGET_GENES, MIR335_3P, MIR3658, MIR4262, MIR561_3P, MIR4766_5P, MIR7154_5P, MIR595, MIR3614_3P, MIR1243
GO Biological Process (0):
GO Molecular Function (2): guanyl-nucleotide exchange factor activity (GO:0005085), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
716 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ECT2L | FBXO48 | Q5FWF7 | 590 |
| ECT2L | FBXO47 | Q5MNV8 | 587 |
| ECT2L | CCDC28A | Q8IWP9 | 530 |
| ECT2L | NPIPA7 | E9PJI5 | 506 |
| ECT2L | Q8WV35 | Q8WV35 | 425 |
| ECT2L | LMO7 | Q8WWI1 | 418 |
| ECT2L | FGD5 | Q6ZNL6 | 416 |
| ECT2L | FBXL15 | Q9H469 | 410 |
| ECT2L | ARHGEF19 | Q8IW93 | 402 |
| ECT2L | FBXL22 | Q6P050 | 402 |
| ECT2L | FBXL13 | Q8NEE6 | 398 |
| ECT2L | FBXO25 | Q8TCJ0 | 385 |
| ECT2L | FBXO33 | Q7Z6M2 | 382 |
| ECT2L | FBXL7 | Q9UJT9 | 376 |
| ECT2L | FBXL14 | Q8N1E6 | 375 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GSTM3 | ECT2L | psi-mi:“MI:0914”(association) | 0.530 |
| GSTM3 | GSTM2 | psi-mi:“MI:0914”(association) | 0.530 |
| ECT2L | HMGA1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ECT2L | HNRNPC | psi-mi:“MI:0915”(physical association) | 0.400 |
| ECT2L | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ECT2L | NEFL | psi-mi:“MI:0914”(association) | 0.350 |
| DGKZ | RRP8 | psi-mi:“MI:0914”(association) | 0.350 |
| ECT2L | TOMM40 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF436 | PNLIPRP2 | psi-mi:“MI:0914”(association) | 0.350 |
| KCTD19 | ECT2L | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (34): ECT2L (Affinity Capture-MS), ECT2L (Affinity Capture-MS), ECT2L (Proximity Label-MS), ECT2L (Proximity Label-MS), ECT2L (Proximity Label-MS), ECT2L (Affinity Capture-MS), ECT2L (Affinity Capture-MS), CHP1 (Affinity Capture-MS), CTNNA1 (Affinity Capture-MS), INA (Affinity Capture-MS), MLLT11 (Affinity Capture-MS), MRPL10 (Affinity Capture-MS), NEFL (Affinity Capture-MS), PKP2 (Affinity Capture-MS), PSMA5 (Affinity Capture-MS)
ESM2 similar proteins: A0A0G2JEB6, A0JM56, B0DOB4, B0FXQ5, B1ANS9, B4F7L9, B4GQJ7, B5DHW4, B7FF06, B7FF07, B7FF08, B7FF09, B7FF12, C5IAW9, F1LW30, F1P4W9, O08747, O95185, P0DM40, Q008S8, Q18264, Q32NR9, Q3V0B4, Q402B2, Q4G0P3, Q5R4M2, Q5T0N1, Q5XI14, Q6AXU1, Q6DCF6, Q6NRS1, Q6P2C0, Q6P5D8, Q6UXZ4, Q6ZTR5, Q6ZU64, Q761X5, Q7T2Z5, Q80W93, Q86YR7
Diamond homologs: A1C7E4, A1CBP8, A1CUD6, A1DDL6, A1DHW6, A1DP19, A2QCU8, A2R3Z3, A3LNI7, A4RJV3, A5D7H2, A7EKM8, B0XM00, B0XTS1, B2VWG7, B6GZA1, B6Q4Z5, B6QC06, B6QC56, B8M0Q1, B8M7Q5, B8NGT5, C0S902, C1GB49, C5FP68, C5GVJ9, C5JD40, D1ZEM6, D4AM37, D4D8P3, L7N1X6, O43815, O55106, P0DL28, P39014, P58404, P58405, P70483, P87053, Q00659
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
165 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 111 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4350 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:138838496:G:GT | donor_gain | 1.0000 |
| 6:138843227:TAAGA:T | donor_gain | 1.0000 |
| 6:138843228:AAGA:A | donor_gain | 1.0000 |
| 6:138843230:GA:G | donor_gain | 1.0000 |
| 6:138843232:G:GG | donor_gain | 1.0000 |
| 6:138844410:A:AG | acceptor_gain | 1.0000 |
| 6:138844411:G:GG | acceptor_gain | 1.0000 |
| 6:138868102:GGGCA:G | acceptor_gain | 1.0000 |
| 6:138868207:G:GG | donor_gain | 1.0000 |
| 6:138812929:GCAAA:G | donor_gain | 0.9900 |
| 6:138813336:GACAG:G | donor_gain | 0.9900 |
| 6:138814486:TATAG:T | acceptor_gain | 0.9900 |
| 6:138814487:ATAGC:A | acceptor_gain | 0.9900 |
| 6:138814488:TAG:T | acceptor_gain | 0.9900 |
| 6:138838496:G:T | donor_gain | 0.9900 |
| 6:138843229:AGAG:A | donor_loss | 0.9900 |
| 6:138843230:GAGTA:G | donor_loss | 0.9900 |
| 6:138843231:AGT:A | donor_loss | 0.9900 |
| 6:138843232:G:A | donor_loss | 0.9900 |
| 6:138843233:T:A | donor_loss | 0.9900 |
| 6:138843234:AAGTA:A | donor_loss | 0.9900 |
| 6:138844410:AGAG:A | acceptor_gain | 0.9900 |
| 6:138844411:GA:G | acceptor_gain | 0.9900 |
| 6:138844411:GAGG:G | acceptor_gain | 0.9900 |
| 6:138844411:GAGGA:G | acceptor_gain | 0.9900 |
| 6:138844578:GCG:G | donor_gain | 0.9900 |
| 6:138844581:G:GG | donor_gain | 0.9900 |
| 6:138849264:TCCAG:T | acceptor_loss | 0.9900 |
| 6:138849265:CCAGA:C | acceptor_loss | 0.9900 |
| 6:138849267:AGA:A | acceptor_loss | 0.9900 |
AlphaMissense
5958 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:138843057:T:A | W141R | 0.993 |
| 6:138843057:T:C | W141R | 0.993 |
| 6:138838494:T:A | W108R | 0.991 |
| 6:138838494:T:C | W108R | 0.991 |
| 6:138854076:T:A | W374R | 0.991 |
| 6:138854076:T:C | W374R | 0.991 |
| 6:138843015:T:A | W127R | 0.990 |
| 6:138843015:T:C | W127R | 0.990 |
| 6:138814536:T:A | W38R | 0.989 |
| 6:138814536:T:C | W38R | 0.989 |
| 6:138842988:T:A | W118R | 0.986 |
| 6:138842988:T:C | W118R | 0.986 |
| 6:138902580:T:A | W890R | 0.983 |
| 6:138902580:T:C | W890R | 0.983 |
| 6:138843059:G:C | W141C | 0.982 |
| 6:138843059:G:T | W141C | 0.982 |
| 6:138865073:T:A | W457R | 0.982 |
| 6:138865073:T:C | W457R | 0.982 |
| 6:138843002:C:G | C122W | 0.980 |
| 6:138885685:T:C | L705P | 0.978 |
| 6:138813305:T:A | W11R | 0.977 |
| 6:138813305:T:C | W11R | 0.977 |
| 6:138843000:T:C | C122R | 0.976 |
| 6:138814505:A:C | R27S | 0.974 |
| 6:138814505:A:T | R27S | 0.974 |
| 6:138814552:G:C | R43P | 0.974 |
| 6:138862654:T:C | L409P | 0.973 |
| 6:138900998:T:C | L822P | 0.973 |
| 6:138842990:G:C | W118C | 0.971 |
| 6:138842990:G:T | W118C | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000012133 (6:138843140 T>C), RS1000144186 (6:138869437 G>A), RS1000156601 (6:138835124 A>T), RS1000252896 (6:138826800 GGT>G), RS1000271444 (6:138887083 C>T), RS1000327183 (6:138820727 C>CT), RS1000351614 (6:138802741 G>T), RS1000373392 (6:138831536 T>A), RS1000379020 (6:138872505 C>T), RS1000406023 (6:138869644 C>T), RS1000437181 (6:138878719 T>A,C), RS1000489521 (6:138831136 C>T), RS1000491756 (6:138794340 G>A,C), RS1000494034 (6:138884405 A>T), RS1000517695 (6:138854298 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003208_5 | Colorectal or endometrial cancer | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004230 | endometrial neoplasm |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs11155012 | Efficacy | 3 | anthracyclines and related substances | Breast Neoplasms |
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs11155012 | ECT2L | 3 | 1.75 | 1 | anthracyclines and related substances |
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| 2,6-dichloro-(1,4)benzoquinone | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.